NLGN4Y
Basic information
Region (hg38): Y:14522573-14845654
Links
Phenotypes
GenCC
Source:
- male infertility with azoospermia or oligozoospermia due to single gene mutation (Limited), mode of inheritance: YL
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NLGN4Y gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 2 | |||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 3 | 3 | 1 |
Variants in NLGN4Y
This is a list of pathogenic ClinVar variants found in the NLGN4Y region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
Y-14622379-G-A | Uncertain significance (Jun 21, 2018) | |||
Y-14824201-C-T | Benign (Jun 07, 2017) | |||
Y-14829869-T-C | Likely benign (Aug 01, 2023) | |||
Y-14830121-C-A | Uncertain significance (Jan 06, 2017) | |||
Y-14840423-C-T | Uncertain significance (Feb 23, 2022) | |||
Y-14840785-C-T | Likely benign (Aug 04, 2017) | |||
Y-14840887-C-T | Likely benign (Apr 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NLGN4Y | protein_coding | protein_coding | ENST00000355905 | 5 | 323013 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0994 | 0.870 | 67952 | 5 | 0 | 67957 | 0.0000368 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.42 | 118 | 170 | 0.694 | 0.0000287 | 5409 |
Missense in Polyphen | 59 | 101 | 0.58413 | 2988 | ||
Synonymous | -0.986 | 92 | 80.7 | 1.14 | 0.0000148 | 1612 |
Loss of Function | 1.85 | 3 | 8.98 | 0.334 | 0.00000142 | 321 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000420 | 0.000420 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000631 | 0.0000314 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Putative neuronal cell surface protein involved in cell- cell-interactions.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human);Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.233
- hipred
- N
- hipred_score
- 0.247
- ghis
- 0.497
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.181
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- neuron cell-cell adhesion;learning;social behavior;synaptic vesicle endocytosis;modulation of chemical synaptic transmission;vocalization behavior;postsynaptic membrane assembly;presynaptic membrane assembly;presynapse assembly
- Cellular component
- plasma membrane;integral component of plasma membrane;cell surface;postsynaptic density;cell junction;synapse;postsynaptic membrane;spanning component of membrane;presynapse;symmetric, GABA-ergic, inhibitory synapse;asymmetric, glutamatergic, excitatory synapse
- Molecular function
- protein binding;signaling receptor activity;neurexin family protein binding;cell adhesion molecule binding;scaffold protein binding